Benefits of ticagrelor, aspirin for stroke outweigh risks over 30 days

The benefits of ticagrelor and aspirin outweighed the risk for major hemorrhage in patients with mild to moderate ischemic stroke or at high risk for transient ischemic attack during 30 days of treatment, according to a Neurology study.
“Due to their pharmacological effects, long-term treatment with P2Y12 inhibitors is associated with an increased risk of bleeding, which has triggered interest in defining the duration of therapy with the best benefit-risk profile,” Yongjun Wang, MD, of Beijing Tiantan Hospital and Capital Medical University, and colleagues wrote.
Researchers sought

The benefits of ticagrelor and aspirin outweighed the risk for major hemorrhage in patients with mild to moderate ischemic stroke or at high risk for transient ischemic attack during 30 days of treatment, according to a Neurology study.
“Due to their pharmacological effects, long-term treatment with P2Y12 inhibitors is associated with an increased risk of bleeding, which has triggered interest in defining the duration of therapy with the best benefit-risk profile,” Yongjun Wang, MD, of Beijing Tiantan Hospital and Capital Medical University, and colleagues wrote.
Researchers sought